Correction to: The safety of Covid-19 mRNA vaccines: a review

Correction to: The safety of Covid-19 mRNA vaccines: a review

Bibliographic Details
Main Authors:	Pratibha Anand, Vincent P. Stahel
Format:	Article
Language:	English
Published:	BMC 2021-05-01
Series:	Patient Safety in Surgery
Online Access:	https://doi.org/10.1186/s13037-021-00296-4

Similar Items

Review the safety of Covid-19 mRNA vaccines: a review
by: Pratibha Anand, et al.
Published: (2021-05-01)

COVID-19 mRNA Vaccine and Myocarditis
by: Balraj Singh, et al.
Published: (2021-06-01)

Nanotechnology-Enabled COVID-19 mRNA Vaccines
by: Yu Gao, et al.
Published: (2021-08-01)

Post-mRNA COVID-19 Vaccination Myocarditis
by: Abhishek Matta, et al.
Published: (2021-08-01)

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
by: Polack, Fernando P, et al.
Published: (2021)

Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination
by: Suzanne M de la Monte, et al.
Published: (2021-10-01)

Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
by: Shyh Poh Teo
Published: (2021-09-01)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
by: Wey Wen Lim, et al.
Published: (2021-09-01)

Thymic hyperplasia after mRNA based Covid-19 vaccination
by: Julia von Tresckow, Dr., et al.
Published: (2021-12-01)

Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
by: Mohammad N. Uddin, et al.
Published: (2021-09-01)

Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database
by: Ahn, J.G, et al.
Published: (2022)

Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
by: Andrea Lombardi, et al.
Published: (2021-03-01)

Immune Response to COVID-19 mRNA Vaccine—A Pilot Study
by: Andrzej Lange, et al.
Published: (2021-05-01)

May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines?
by: Pedro Giavina-Bianchi, et al.
Published: (2021-04-01)

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
by: Ronald B. Brown
Published: (2021-02-01)

Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease
by: Abdulmajeed, J., et al.
Published: (2022)

An Outbreak of COVID-19 among mRNA-Vaccinated Nursing Home Residents
by: Fabrizio Faggiano, et al.
Published: (2021-08-01)

Deep sequence modelling for predicting COVID-19 mRNA vaccine degradation
by: Talal S. Qaid, et al.
Published: (2021-06-01)

Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
by: Katerina Pavenski
Published: (2021-07-01)

The Successful Vaccination of an IVIgG Naive CVID Patient with an mRNA COVID-19 Vaccine
by: Maaz Jalil DO, et al.
Published: (2021-10-01)

COVID-19 mRNA vaccination leading to CNS inflammation: a case series
by: Bakshi, R., et al.
Published: (2022)

Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
by: Yuhua Weng, et al.
Published: (2021-05-01)

Human IgG and IgA responses to COVID-19 mRNA vaccines.
by: Adam V Wisnewski, et al.
Published: (2021-01-01)

Liposomes and mRNA: Two technologies together create a COVID-19 vaccine
by: Gregory Gregoriadis
Published: (2021-12-01)

Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine
by: Marie-Estelle Gaignard, et al.
Published: (2021-08-01)

New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccination
by: Joshua Kaminetsky, et al.
Published: (2021-09-01)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
by: Chiranjib Chakraborty, et al.
Published: (2021-07-01)

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
by: Kirill V. Kalnin, et al.
Published: (2021-04-01)

Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
by: Karolina Polewska, et al.
Published: (2021-07-01)

mRNA-Based Vaccines
by: Frank Kowalzik, et al.
Published: (2021-04-01)

Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination
by: Chou, J., et al.
Published: (2022)

The Ecological Footprint of COVID-19 mRNA Vaccines: Estimating Greenhouse Gas Emissions in Germany
by: Peter Kurzweil, et al.
Published: (2021-07-01)

Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine
by: Nicholas Fowler, et al.
Published: (2021-09-01)

Recurrence of Thrombotic Thrombocytopenic Purpura after mRNA-1273 COVID-19 Vaccine Administered Shortly after COVID-19
by: Korin Karabulut, et al.
Published: (2021-01-01)

COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study
by: Nadia Charepe, et al.
Published: (2021-09-01)

COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence?
by: Arash Maleki, et al.
Published: (2021-07-01)

Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers
by: Yu-Mi Wi, et al.
Published: (2021-08-01)

mRNA Innovates the Vaccine Field
by: Norbert Pardi
Published: (2021-05-01)

mRNA Vaccines against Flaviviruses
by: Clayton J. Wollner, et al.
Published: (2021-02-01)

mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)